MediPal Holdings Corporation
Notice Regarding Recognition of Gain on Sale of Investment Securities (Extraordinary Income)
Recognized gain on sale of investment securities of 15,485 million yen. Of that amount, 6,061 million yen will be recorded in the consolidated accounting period for Q1 of the fiscal year ending March 2027. The sale was conducted as part of corporate governance measures to reduce policy holdings. For future impact, refer to the Notice of Revision of Full-Year Consolidated Earnings Forecasts.
Key Figures
- Gain on Sale of Investment Securities (Extraordinary Income): 15,485 million yen
- Of which recorded in Q1 of FY ending March 2027: 6,061 million yen
- Sale period: May 2026～October 2026
AI要約
Key Points of the News
MediPal Holdings Corporation recognized a gain on sale of investment securities totaling 15,485 million yen due to the sale and reduction of some of its held investment securities. Of this, 6,061 million yen is scheduled to be recorded in the consolidated accounting period for Q1 of the fiscal year ending March 2027. The sales are part of measures to strengthen corporate governance and achieve management mindful of capital costs and share price. For future impacts, refer to the Notice of Revision of Full-Year Consolidated Earnings Forecasts.
Outlook and Impact
The extent to which this gain will affect full-year results is detailed in the Notice of Revision of Full-Year Consolidated Earnings Forecasts published on the same day. The gain is recorded as extraordinary income and may influence future financial indicators and shareholder return policies.
MediPal Holdings Corporation
Company overview · Stock price · Financial data · All IR
